DOCSLIB.ORG

Human Fungal Pathogens

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

This is a free sample of content from Human Fungal Pathogens. Click here for more information on how to buy the book. Index A Anidulafungin ABC1, 188 candidiasis management, 340 ABPA. See Allergic bronchopulmonary aspergillosis structure, 273 Acanthamoeba castellanii,10 Antibody directed cell toxicity, 108 Ace2, 69 Antibody therapy. See Immunotherapy Acrophialophora, 520 Antifungals. See Drug development; specific drugs Acrophialophora fusispora, 520 APECED, 105, 150–151 AD. See Atopic dermatitis App1, 185 AD-HIES. See Autosomal dominant APR1, 239 hyper-immunoglobulin E syndrome ARG4,68–69 Adenylate kinase, lysis assay for drug development, 277 Armellaria mellea,26 ADH5, 172 Ascomycetes, 196 Adh5, 371 Ascomycota, 4–8, 11–14, 23–25, 33, 120 AFR1, 370 Ashbya gossypii, 196 Afr1, 367 Aspergillosis. See Allergic bronchopulmonary AIDS. See HIV/AIDS aspergillosis; Invasive aspergillosis AIF1,84 Aspergillus Allergic bronchopulmonary aspergillosis (ABPA), 439 evolution, 24, 27, 31 Als3, 168–169, 202, 220–223, 245, 293, 417–418 overview, 12–14 ALS proteins, 164–165 Aspergillus flavus, 52, 435–436 Alternaria, 14, 521–522 Aspergillus fumigatus Alternaria alternata, 124, 519, 521–522 amino acid metabolism, 240 Alternaria chlamydospora, 521–522 aspergillosis. See Invasive aspergillosis Alternaria dianthicola, 521 B-cell immunity, 107–108 Alternaria infectoria, 521–522 biofilm, 162, 170, 173–174 Alternaria longpipes, 521 carbon assimilation, 240, 243 Alternaria tennissima, 521 cell invasion Amphotericin B adherence mechanisms, 224–225 adverse effects, 328 molecular mechanisms, 224 biofilms in resistance, 173–174 overview, 223–224 candidiasis management, 339–340, 352 clinical trials Cryptococcus treatment, 342–345, 350–351 overview, 354–355 endemic fungi infection management, 357 prospects, 355 entomophthoramycosis management, 506–507 dendritic cell invasive aspergillosis management, 355 immunotherapy, 290 mechanism of action, 272 response, 94, 97 mucormycosis management, 487–488 diagnosis, 265 pharmacodynamics of lipid formulations, 307–308 drug resistance, 368 structure, 273 ecology, 433 AN2690, 279–280 evolution, 24, 26–29, 32 Aneuploidy. See also Ploidy change innate immunity, 121–122, 124, 126–127 consequences, 83–85 iron metabolism, 246 loss of heterozygosity, 84–85 laboratory identification and biology, 433–436 mechanisms in generation, 81–83 macrophage engulfment, survival, and replication, overview, 80–81 184–185 Anhidrotic ectodermal dysplasia with overview, 12–13 immunodeficiency (EDA-IE), 153 pattern recognition receptors, 100 563 © 2015 by Cold Spring Harbor Laboratory Press. All rights reserved. This is a free sample of content from Human Fungal Pathogens. Click here for more information on how to buy the book. Index Aspergillus fumigatus (Continued) Basidomycota, 14 ploidy change, 75–77 Batrachochytrichium,25 section Fumigati, 432–433 B cell, pathogen response, 107–108 sexual reproduction BCR1, 165, 168 drug resistance role, 53 Bcr1, 167, 169, 420 other Aspergillus species, 521 Bcy1, 203 overview, 51 Bgl2, 172 pathogen population biology significance, Biatriospora, 522 52–53 Biatriospora mackinonii, 522 sexual cycle, 51–52 Bin1, 207 T-cell immunity, 107 Biofilm vaccination, 291 comparative genomics, 168–169 zinc assimilation, 247 drug resistance Aspergillus lentulus,52–53 azoles, 371 Aspergillus nidulans echinocandins, 374 aspergillosis. See Invasive aspergillosis extracellular matrix chronic granulomatous disease, 146 Candida laboratory identification and biology, 433–436 drug resistance role, 170–171 morphogenesis, 195, 198 eDNA in drug resistance, 173 ploidy change, 76–78 glucan production, 171–172 Aspergillus niger, 52, 434–436 production, 169–170 Aspergillus oryzae, 197 Aspergillus drug resistance, 173–174 Aspergillus terreus, 52, 434–435 genetic control of development, 162, 164–168 Aspf2, 247 multispecies biofilms, 168 Ato5, 238 prospects for study, 174 Atopic dermatitis (AD), Malassezia role, 475–476 rationale for study, 161–162 Atx1, 397 species and clinical significance, 163–164 Aureobasidium, 522 Bipolaris, 14, 522 Autosomal dominant hyper-immunoglobulin Bipolaris australiensis, 522 E syndrome (AD-HIES), 148–149 Bipolaris hawaiiensis, 519, 522 Autosomal recessive hyper-immunoglobulin Bipolaris spicifera, 522 E syndrome, 153 Black fungi Axl2, 198 Acrophialophora, 520 Alternaria, 520–522 antifungal therapy, 530–531 B Aureobasidium, 522 Backusella circina, 494 Biatriospora, 522 Bad1, 228 Bipolaris, 522 Basidiobolus Chaetomium, 523 clinical features, 502–503 Chladophialophora, 523 diagnosis, 505–506 clinical spectrum of diseases, 518–521 ecology, 496–497 Curvularia, 523 epidemiology, 496–497 Cyphellophora, 523–524 evolution, 25 diagnosis, 529–530 life cycle, 499 Exophiala, 524–525 management, 506–507 Exserohilum, 525 overview, 5–4, 494–495 Falciformispora, 525 pathogenesis, 502 Fonsecaea, 525–526 taxonomy, 495–498 Hortaea, 526 Basidiobolus heterosporus, 497 Knufia, 526 Basidiobolus lacerate, 497 Madurella, 526 Basidiobolus meristosporus, 497 Medicopsis, 526 Basidiobolus microspores, 497 Neoscytalidium, 526–527 Basidiobolus ranarum, 4, 496–497, 488.503, 506–507 Ochoconis, 527 Basidiomycetes, 196–197 overview, 517–518 Basidiomycota, 8–11, 25–26, 120 Phaeoacremonium, 527 564 © 2015 by Cold Spring Harbor Laboratory Press. All rights reserved. This is a free sample of content from Human Fungal Pathogens. Click here for more information on how to buy the book. Index Phialophora, 527 drug resistance, 367–368, 370–371 Phoma, 527–528 epidemiology, 413–414 Pseudochaetosphaeronema, 528 evolution, 26–28, 30–33 Pyrenochaeta, 528 genome profiling Rhinocladiella, 528 gene-deletion methods, 68–69 Trematosphaeria, 528–529 homozygous knockouts, 69 Veronaea, 529 industry collections, 69–70 Verruconis, 529 resources, 65 Blastomyces, 4–5, 24, 27 transcription factor knockouts, 69 Blastomyces dermatitidis genome studies, 416–419 cell invasion, 228 innate immunity, 121–122, 124–126, 129 diagnosis, 266 iron metabolism, 245–246 epidemiology, 452 life cycle and genome, 67–68 evolution, 26 macrophage engulfment, survival, and replication, morphogenesis, 201, 205 180–184 T-cell immunity, 102, 107 morphogenesis, 200–209 thermal dimorphism, 452–453 nitrogen assimilation, 237–240 vaccination, 292 overview, 11–12 Bni1, 199 parasexual reproduction, 47–51 Brg1, 204 pattern recognition receptors, 100–102 Bud1, 198 ploidy change, 74–75, 77–79 Bud3, 198 vaccination, 291, 294 Bud4, 198 zinc assimilation, 247 Bud8, 198 Candida dubliniensis Bud9, 198 evolution, 26, 31 genome studies, 418–419 Candida glabrata C carbon assimilation, 240 CalA, 224 drug resistance, 370–371 CAN1, 239 epidemiology, 413–414 CAN2, 399 evolution, 33 Candida genome studies, 420–422 evolution, 24, 28, 30–31 iron metabolism, 245–246 overview, 11–12 macrophage engulfment, survival, and replication, pathogens, 413–414 180–184 taxonomy, 413–416 nitrogen assimilation, 237, 239 treatment principles. See Candida treatment overview, 11 principles zinc assimilation, 247 vaginosis mycobiome, 560 Candida guillermondii, 420 Candida albicans Candida krusei aneuploidy, 80, 82, 85 epidemiology, 413–414 B-cell immunity, 107–108 overview, 11 biofilm Candida lusitaniae, 1, 420, 77, 82 comparative genomics, 168–169 Candida metapsilosis,28 drug development, 276 Candida orthopsilosis,28 extracellular matrix Candida parapsilosis drug resistance role, 170–171 biofilms 166, 168–169 eDNA in drug resistance, 173 cell invasion, 223 glucan production, 171–172 epidemiology, 413–414 production, 169–170 evolution 28 genetic control of development, 162, 164–168 genome studies, 419–420 multispecies biofilms, 168 nitrogen assimilation, 237 carbon assimilation, 240–244 overview 11 cell invasion Candida treatment principles endothelial cell, 122–123 antifungal agents and spectrum of activity, 340 epithelial cell, 119–122 clearance confirmation, 339 565 © 2015 by Cold Spring Harbor Laboratory Press. All rights reserved. This is a free sample of content from Human Fungal Pathogens. Click here for more information on how to buy the book. Index Candida treatment principles (Continued) CDR2, 367–368, 370 clinical trials CDR3, 367 overview, 352–353 CDR4, 367 prospects, 353 CDR11, 367 disseminated infection CFEM proteins, 164, 169, 173 bone, 341 Cfl1, 209, 225 central nervous system, 341 CfmA, 224 endocardium, 341 CfmC, 224 eye, 339 Cfo1, 246, 399 renal tract, 339, 341 Cft1, 246 drug resistance. See Drug resistance CGD. See Chronic granulomatous disease general treatment principles. See Treatment Chaetomium, 523 principles, mold infection Chaetomium atrobrunneum, 523 meningioencephalitis in HIV, 339 Chaetomium funicola, 523 overview, 337–338 Chaetomium globusum, 523 rapid and effective antifungal therapy, 338 Chaetomium perlucidum, 523 source removal, 338 Chaetomium strumarium, 523 therapy modification according to species Chitin synthase, drug resistance, 374–376 determination and susceptibility Chladophialophora, 523 testing, 338 Chladophialophora arxii, 523 Candida tropicalis Chladophialophora bantiana, 523 epidemiology, 413–414 Chladophialophora boppii, 523 evolution, 28 Chladophialophora carrionni, 523 genome studies, 77, 419–420 Chladophialophora devriesii, 523 overview, 11 Chladophialophora emmonsii, 523 Cap1p, 183 Chladophialophora saturnica, 523 Carbon assimilation Chromoblastomycosis, 518 central carbon metabolism Chronic granulomatous disease (CGD), regulation in host niches, 242–243 fungal infection susceptibility, 141, regulatory rewiring, 241–242 146, 439 overview, 240–241 Chs2, 375 virulence factor impact, 243–244 Chs8, 375
Recommended publications
  • Estimated Burden of Serious Fungal Infections in Ghana

    Estimated Burden of Serious Fungal Infections in Ghana

    Journal of Fungi Article Estimated Burden of Serious Fungal Infections in Ghana Bright K. Ocansey 1, George A. Pesewu 2,*, Francis S. Codjoe 2, Samuel Osei-Djarbeng 3, Patrick K. Feglo 4 and David W. Denning 5 1 Laboratory Unit, New Hope Specialist Hospital, Aflao 00233, Ghana; [email protected] 2 Department of Medical Laboratory Sciences, School of Biomedical and Allied Health Sciences, College of Health Sciences, University of Ghana, P.O. Box KB-143, Korle-Bu, Accra 00233, Ghana; [email protected] 3 Department of Pharmaceutical Sciences, Faculty of Health Sciences, Kumasi Technical University, P.O. Box 854, Kumasi 00233, Ghana; [email protected] 4 Department of Clinical Microbiology, School of Medical Sciences, Kwame Nkrumah University of Science and Technology, Kumasi 00233, Ghana; [email protected] 5 National Aspergillosis Centre, Wythenshawe Hospital and the University of Manchester, Manchester M23 9LT, UK; [email protected] * Correspondence: [email protected] or [email protected] or [email protected]; Tel.: +233-277-301-300; Fax: +233-240-190-737 Received: 5 March 2019; Accepted: 14 April 2019; Published: 11 May 2019 Abstract: Fungal infections are increasingly becoming common and yet often neglected in developing countries. Information on the burden of these infections is important for improved patient outcomes. The burden of serious fungal infections in Ghana is unknown. We aimed to estimate this burden. Using local, regional, or global data and estimates of population and at-risk groups, deterministic modelling was employed to estimate national incidence or prevalence. Our study revealed that about 4% of Ghanaians suffer from serious fungal infections yearly, with over 35,000 affected by life-threatening invasive fungal infections.
  • Fundamental Medical Mycology Errol Reiss

    Fundamental Medical Mycology Errol Reiss

    Fundamental Medical Mycology Fundamental Medical Mycology Errol Reiss Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia H. Jean Shadomy Department of Microbiology and Immunology, Virginia Commonwealth University, School of Medicine, Richmond, Virginia G. Marshall Lyon, III Department of Medicine, Division of Infectious Diseases, Emory University, School of Medicine, Atlanta, Georgia A JOHN WILEY & SONS, INC., PUBLICATION This book was written by Errol Reiss in his private capacity. No official support or endorsement by the Centers for Disease Control and Prevention, Department of Health and Human Services is intended, nor should be inferred. Copyright 2012 by Wiley-Blackwell. All rights reserved Published by John Wiley & Sons, Inc., Hoboken, New Jersey Published simultaneously in Canada No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording, scanning, or otherwise, except as permitted under Section 107 or 108 of the 1976 United States Copyright Act, without either the prior written permission of the Publisher, or authorization through payment of the appropriate per-copy fee to the Copyright Clearance Center, Inc., 222 Rosewood Drive, Danvers, MA 01923, (978) 750-8400, fax (978) 750-4470, or on the web at www.copyright.com. Requests to the Publisher for permission should be addressed to the Permissions Department, John Wiley & Sons, Inc., 111 River Street, Hoboken, NJ 07030, (201) 748-6011, fax (201) 748-6008, or online at http://www.wiley.com/go/permission. Limit of Liability/Disclaimer of Warranty: While the publisher and author have used their best efforts in preparing this book, they make no representations or warranties with respect to the accuracy or completeness of the contents of this book and specifically disclaim any implied warranties of merchantability or fitness for a particular purpose.
  • Uncommon Fungi and Related Species

    Uncommon Fungi and Related Species

    Uncommon Fungi and 268 Related Species Duane R. Hospenthal SHORT VIEW SUMMARY SCEDOSPORIUM APIOSPERMUM Diagnosis FUSARIUMM SPP. (PSEUDALLESCHERIA BOYDIII) SPECIES Diagnosis is made by culture recovery from the } Definition COMPLEX infected site. } Can cause disseminated infection in } Because L. prolificanss may colonize airways, Definition immunocompromised patients. sputum cultures may not reflect infection. } Infection of the lungs, bones and joints, or } Common cause of keratitis and other eye central nervous system (CNS); may be Therapy infections in contact lens wearers and disseminated. } No effective therapy. Consider voriconazole following trauma. } Also causes mycetoma (see Chapter 261). with amphotericin B. } Skin and soft tissue infection after trauma, onychomycosis; can cause mycetoma. Epidemiology DARK-WALLED FUNGI (BIPOLARIS, } Typically occurs in the immunocompromised or EXOPHIALA, EXSEROHILUM, Epidemiology following trauma. PHIALOPHORA, OCHROCONIS, } Common plant pathogens; found in soil and } CNS infection in immunocompetent persons CURVULARIA, OTHERS) organic debris. after near drowning. Have been recovered in hospital water supplies. Definition } } Organism can be found in soil and fresh water, } This infection involves fungi that have melanin Microbiology especially stagnant or polluted. in their cell walls and may appear dark walled } The most common species infecting humans Microbiology in tissue. belong to one of three species complexes: } Scedosporium apiospermum, Scedosporium } Infection is often termed Fusarium solani, Fusarium oxysporum, or boydiii (formerly Pseudallescheria boydiii), and “phaeohyphomycosis” and typically presents Fusarium fujikuroi, although the number of Scedosporium aurantiacumm are the most as localized skin and soft tissue infections, species identified as causing infection is common species infecting humans. CNS infections, or allergic sinusitis. increasing as molecular methods of } Identification is typically made by DNA } Dark-walled fungi that cause identification have supplanted morphology.
  • Fungi Infections

    Fungi Infections

    FUNGAL INFECTIONS mycology mycoses fungemia exo-antigen fungal antigenemia biomarker pre-emptive therapy Fungi FUNGI BACTERIA nucleus eukaryotes prokaryotes cell membrane sterols (ergosterol)* - cell wall chitin, mannan, glucan, murein, teichoic acid, chitosan proteins oxygen almost all strict aerobes facultative and obligate aerobes and anaerobes, - Heterotrophs requiring organic carbon source for growth ( biotrophic, saprophyte) - Extracellular enzymes - host defense: cell-mediated immunity (role of antibodies is minor) -> neutrophil phagocytosis and killing Antifungal agents- mode of action - Polyenes (amphotericinB, nystatines, pimarcin) - Azoles (ketokonazole, itraconazole, fluconazole, vericonazole, posaconazole) - Echinocandins (caspofungin, mikafungin, anidulafungin ) - Nucleoside analogs(antimetabolites): (5 fluorocytosine) - Allylamines: (tebinafine) Fungal morphotypes Unicellular form (Yeast) Yeasts spherical or ellipsoid fungal cells reproduce by budding Mycelial form : moulds, dermathophytes Molds hyphal or mycelial form of growth branching filaments (filamentous) . Fungal morphotypes Unicellular form (Yeast) FUNGUS FAMILY YEAST MOLDs & dermatophytes Candida, Cryptococcus, Dymorphic fungi Malessezia, Geotrichum, Aspergillus, Penicillium, Blastomyces, Coccidioides, Trichosporon, Rodotorula Mucor, Rhizopus, Fusarium, Histoplasma, Paracoccidioides etc. Cladosporium, or Scopulariopsis Dimorphic fungi – have two growth forms: molds & yeast, which develope under different growth conitions phaeohyphomycetes Most authorities use the
  • 10-ELS-OXF Kurtzman1610423 CH002 7..20

    10-ELS-OXF Kurtzman1610423 CH002 7..20

    Part II Importance of Yeasts Kurtzman 978-0-444-52149-1 00002 Kurtzman 978-0-444-52149-1 00002 Chapter 2 c0002 Yeasts Pathogenic to Humans Chester R. Cooper, Jr. regularly encounter the organisms described below. In fact, many s0010 1. INTRODUCTION TO THE MEDICALLY medical mycologists spend entire careers without direct clinical expo- IMPORTANT YEASTS sure to many of these fungi. Rather, the purpose of this review is to enlighten the non-medical mycologist as to the diversity of yeast and p0010 Prior to global emergence of the human immunodeficiency virus mold species regularly associated with human and animal disease (HIV), which is the causative agent of acquired immunodeficiency that also, at least in part, present a unicellular mode of growth in vivo. syndrome (AIDS), approximately 200 fungal pathogens were recog- The following descriptions present a concise overview of the key p0025 nized from among the more than 100,000 then-known fungal spe- biological and clinical features of these fungi. Where appropriate, refer- cies (Kwon-Chung and Bennett 1992, Rippon 1988). About 50 of ences to recent reviews of particular disease agents and their patholo- these species were regularly associated with fungal disease (myco- gies are provided. For a global perspective of fungal diseases, including sis). Since then, there has been a concurrent dramatic increase in in-depth clinical discussions of specific pathologies, diagnoses, and both the number of known fungal species and the incidence of treatments, the reader is referred to several outstanding and recently mycoses that they cause. Moreover, the spectrum of pathogenic fungi published texts (Anaissie et al.
  • Epidemiological, Clinical and Diagnostic Aspects of Sheep Conidiobolomycosis in Brazil

    Epidemiological, Clinical and Diagnostic Aspects of Sheep Conidiobolomycosis in Brazil

    Ciência Rural, Santa Maria,Epidemiological, v.46, n.5, p.839-846, clinical mai, and 2016 diagnostic aspects of sheep conidiobolomycosis http://dx.doi.org/10.1590/0103-8478cr20150935 in Brazil. 839 ISSN 1678-4596 MICROBIOLOGY Epidemiological, clinical and diagnostic aspects of sheep conidiobolomycosis in Brazil Aspectos epidemiológicos, clínicos e de diagnóstico da conidiobolomicose ovina no Brasil Carla WeiblenI Daniela Isabel Brayer PereiraII Valéria DutraIII Isabela de GodoyIII Luciano NakazatoIII Luís Antonio SangioniI Janio Morais SanturioIV Sônia de Avila BottonI* — REVIEW — ABSTRACT As lesões da conidiobolomicose normalmente são de caráter granulomatoso e necrótico, apresentando-se sob duas formas Conidiobolomycosis is an emerging disease caused clínicas: rinofacial e nasofaríngea. O presente artigo tem como by fungi of the cosmopolitan genus Conidiobolus. Particular objetivo revisar as principais características da doença em ovinos, strains of Conidiobolus coronatus, Conidiobolus incongruus and particularizando a epidemiologia, assim como os aspectos clínicos Conidiobolus lamprauges, mainly from tropical or sub-tropical e o diagnóstico das infecções causadas por Conidiobolus spp. no origin, cause the mycosis in humans and animals, domestic or Brasil. Neste País, a enfermidade é endêmica nas regiões nordeste wild. Lesions are usually granulomatous and necrotic in character, e centro-oeste, afetando ovinos predominantemente de raças presenting two clinical forms: rhinofacial and nasopharyngeal. deslanadas, ocasionando a morte na grande maioria dos casos This review includes the main features of the disease in sheep, with estudados. As espécies do fungo responsáveis pelas infecções an emphasis on the epidemiology, clinical aspects, and diagnosis em ovinos são C. coronatus e C. lamprauges e a forma clínica of infections caused by Conidiobolus spp.
  • A Case Study on Subcutaneous Zygomycosis with Ulcer

    A Case Study on Subcutaneous Zygomycosis with Ulcer

    Int.J.Curr.Microbiol.App.Sci (2013) 2(10): 448-451 ISSN: 2319-7706 Volume 2 Number 10 (2013) pp. 448-451 http://www.ijcmas.com Case report A Case Study on Subcutaneous zygomycosis with ulcer P.Hema Prakash Kumari1, M. SrinivasaRao2, S. Subbarayudu3, Y. Saritha4 and Amrutha Kar5 1,3,4,5Department of Microbiology ASRAM Medical College Eluru, A.P Pin 534004, India 2Department of Pediatrics ASRAM Medical College Eluru, A.P Pin 534004, India *Corresponding author A B S T R A C T K e y w o r d s Subcutaneous mycosis due to Basidiobolus ranarum is endemic in south Subcutaneous India. We hereby report a case of subcutaneous zygomycosis in a 6 months phycomycosis; old female child who presented with a painless, non-tender swelling Basidiobolus progressed to ulcer on the thigh. ranarum; Introduction Routine investigations were normal and x A 6 month female child was brought to ray left thigh showed soft tissue swelling. pediatric department with h/o gradually Tests for HIV negative, swabs were sent increasing painless ulcerated swelling over for bacterial and fungal culture. Bacterial the left thigh. There was history of insect culture was sterile and a 10% potassium bite 4 months ago. The swelling was hydroxide wet mount revealed broad, gradually increasing since then and irregular aseptate hyphae. Growth on progressed to ulcer formation covered by Sabouraud s dextrose agar after 3 days of eschar. incubation at 25 °C showed creamy brown, centrally heaped up, radially folded No discharge was observed. On cutaneous colonies with satellite colonies on the examination there was a single firm, well periphery (Figure 2).
  • Boards' Fodder

    Boards' Fodder

    boards’ fodder Medical Mycology By Adriana Schmidt, MD, and Natalie M. Curcio, MD, MPH. (Updated July 2015*) SUPERFICIAL ORGANISM CLINICAL HISTO/KOH TREATMENT MYCOSES* Pityriasis Malessezia furfur Hypo- or hyper-pigmented Spaghetti & meatballs: Antifungal shampoos and/or versicolor macules short hyphae + yeast PO therapy Tinea nigra Hortaea werneckii (formerly Brown-black non-scaly Branching septate hyphae Topical imidazoles or palmaris Phaeoannellomyces werneckii) macules + budding yeast allylamines Black piedra Piedraia hortae Hard firm black Dark hyphae around concretions acrospores Cut hair off, PO terbinafine, White piedra Trichosporon ovoides or inkin Soft loose white Blastoconidia, imidazoles, or triazoles (formely beigelii) concretions arthroconidia Fluorescent small Microsporum Canis KOH: spores on outside spore ectothrix: M. audouinii of the hair shaft; “Cats And Dogs M. distortum Wood’s lamp --> yellow Sometimes Fight T. schoenleinii fluorescence & Growl” M. ferrugineum+/- gypseum Large spore Trichophyton spp. (T. tonsurans in North America; T. violaceum in KOH: spores within hair Topical antifungals; PO endothrix Europe, Asia, parts of Africa). shaft antifungals for T. manuum, Tinea corporis T. rubrum > T. mentag. Majocchi’s granuloma: T. rubrum capitis, unguium T. pedis Moccasin: T. rubrum, E. floccosum. Interdigital/vesicular: T. mentag T. unguium Distal lateral, proximal and proximal white subungual: T. rubrum. White superficial: T. mentag. HIV: T. rubrum SUBQ MYCOSES** ORGANISM TRANSMISSION CLINICAL HISTO/KOH TREATMENT
  • Monograph on Dematiaceous Fungi

    Monograph on Dematiaceous Fungi

    Monograph On Dematiaceous fungi A guide for description of dematiaceous fungi fungi of medical importance, diseases caused by them, diagnosis and treatment By Mohamed Refai and Heidy Abo El-Yazid Department of Microbiology, Faculty of Veterinary Medicine, Cairo University 2014 1 Preface The first time I saw cultures of dematiaceous fungi was in the laboratory of Prof. Seeliger in Bonn, 1962, when I attended a practical course on moulds for one week. Then I handled myself several cultures of black fungi, as contaminants in Mycology Laboratory of Prof. Rieth, 1963-1964, in Hamburg. When I visited Prof. DE Varies in Baarn, 1963. I was fascinated by the tremendous number of moulds in the Centraalbureau voor Schimmelcultures, Baarn, Netherlands. On the other hand, I was proud, that El-Sheikh Mahgoub, a Colleague from Sundan, wrote an internationally well-known book on mycetoma. I have never seen cases of dematiaceous fungal infections in Egypt, therefore, I was very happy, when I saw the collection of mycetoma cases reported in Egypt by the eminent Egyptian Mycologist, Prof. Dr Mohamed Taha, Zagazig University. To all these prominent mycologists I dedicate this monograph. Prof. Dr. Mohamed Refai, 1.5.2014 Heinz Seeliger Heinz Rieth Gerard de Vries, El-Sheikh Mahgoub Mohamed Taha 2 Contents 1. Introduction 4 2. 30. The genus Rhinocladiella 83 2. Description of dematiaceous 6 2. 31. The genus Scedosporium 86 fungi 2. 1. The genus Alternaria 6 2. 32. The genus Scytalidium 89 2.2. The genus Aurobasidium 11 2.33. The genus Stachybotrys 91 2.3. The genus Bipolaris 16 2.
  • Fungal Allergy and Pathogenicity 20130415 112934.Pdf

    Fungal Allergy and Pathogenicity 20130415 112934.Pdf

    Fungal Allergy and Pathogenicity Chemical Immunology Vol. 81 Series Editors Luciano Adorini, Milan Ken-ichi Arai, Tokyo Claudia Berek, Berlin Anne-Marie Schmitt-Verhulst, Marseille Basel · Freiburg · Paris · London · New York · New Delhi · Bangkok · Singapore · Tokyo · Sydney Fungal Allergy and Pathogenicity Volume Editors Michael Breitenbach, Salzburg Reto Crameri, Davos Samuel B. Lehrer, New Orleans, La. 48 figures, 11 in color and 22 tables, 2002 Basel · Freiburg · Paris · London · New York · New Delhi · Bangkok · Singapore · Tokyo · Sydney Chemical Immunology Formerly published as ‘Progress in Allergy’ (Founded 1939) Edited by Paul Kallos 1939–1988, Byron H. Waksman 1962–2002 Michael Breitenbach Professor, Department of Genetics and General Biology, University of Salzburg, Salzburg Reto Crameri Professor, Swiss Institute of Allergy and Asthma Research (SIAF), Davos Samuel B. Lehrer Professor, Clinical Immunology and Allergy, Tulane University School of Medicine, New Orleans, LA Bibliographic Indices. This publication is listed in bibliographic services, including Current Contents® and Index Medicus. Drug Dosage. The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any change in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means electronic or mechanical, including photocopying, recording, microcopy- ing, or by any information storage and retrieval system, without permission in writing from the publisher.
  • Gastrointestinal Basidiobolomycosis, a Rare and Under-Diagnosed Fungal Infection in Immunocompetent Hosts: a Review Article

    Gastrointestinal Basidiobolomycosis, a Rare and Under-Diagnosed Fungal Infection in Immunocompetent Hosts: a Review Article

    IJMS Vol 40, No 2, March 2015 Review Article Gastrointestinal Basidiobolomycosis, a Rare and Under-diagnosed Fungal Infection in Immunocompetent Hosts: A Review Article Bita Geramizadeh1,2, MD; Mina Abstract 2 2 Heidari , MD; Golsa Shekarkhar , MD Gastrointestinal Basidiobolomycosis (GIB) is an unusual, rare, but emerging fungal infection in the stomach, small intestine, colon, and liver. It has been rarely reported in the English literature and most of the reported cases have been from US, Saudi Arabia, Kuwait, and Iran. In the last five years, 17 cases have been reported from one or two provinces in Iran, and it seems that it has been undiagnosed or probably unnoticed in other parts of the country. This article has Continuous In this review, we explored the English literature from 1964 Medical Education (CME) through 2013 via PubMed, Google, and Google scholar using the credit for Iranian physicians following search keywords: and paramedics. They may 1) Basidiobolomycosis earn CME credit by reading 2) Basidiobolus ranarum this article and answering the 3) Gastrointestinal Basidiobolomycosis questions on page 190. In this review, we attempted to collect all clinical, pathological, and radiological findings of the presenting patients; complemented with previous experiences regarding the treatment and prognosis of the GIB. Since 1964, only 71 cases have been reported, which will be fully described in terms of clinical presentations, methods of diagnosis and treatment as well as prognosis and follow up. Please cite this article as: Geramizadeh B, Heidari M, Shekarkhar G. Gastrointestinal Basidiobolomycosis, a Rare and Under-diagnosed Fungal Infection in Immunocompetent Hosts: A Review Article. Iran J Med Sci.
  • Case Report of Subcutaneous Entomophthoromycosis with Retroperitoneal Invasion

    Case Report of Subcutaneous Entomophthoromycosis with Retroperitoneal Invasion

    RELATO DE CASO/CASE REPORT Revista da Sociedade Brasileira de Medicina Tropical 38(4):348-350, jul-ago, 2005 Case report of subcutaneous entomophthoromycosis with retroperitoneal invasion Relato de caso de entomoftoromicose subcutânea com invasão retroperitoneal Leonora Maciel de Souza Vianna1, 2, Marcus Vinícius Guimarães de Lacerda1 and Mário Augusto Pinto de Moraes1 ABSTRACT The authors describe a case of entomophthoromycosis in a previously healthy patient, who presented with an abscess in the right buttock. After surgical drainage it evolved into a retroperitoneal tumor. The patient improved clinically after resection of the mass and ketoconazole treatment. The histopathological analysis showed the Splendore-Hoeppli phenomenon, suggesting Basidiobolus ranarum infection, a zygomycosis generally restricted to the subcutaneous tissue, with rare gastrointestinal involvement. Key-words: Basidiobolus ranarum. Zygomycosis. Entomophthorales. Clinical features. Histopathology. Splendore-Hoeppli phenomenon. RESUMO Os autores descrevem um caso de entomoftoromicose em paciente previamente saudável, que apresentou abscesso em nádega direita, evoluindo, após drenagem cirúrgica, para tumoração retroperitoneal. Após ressecção da massa, o paciente obteve melhora clínica, em uso de cetoconazol. A análise histopatológica evidenciou fenômeno de Splendore-Hoeppli, sugerindo infecção por Basidiobolus ranarum, uma zigomicose geralmente restrita ao tecido subcutâneo, com raro comprometimento gastrintestinal. Palavras-chaves: Basidiobolus ranarum. Zigomicose.